Patrick has developed deep methodological expertise advising pharma and biotech firms during his more than 10 years in serving clients. His core competencies span across R&D and Commercial, developing solutions from early research asset strategies over late-stage prioritization to medical affairs reorganizations. He is a well-known expert around portfolio management, asset valuations and market entry strategies across a diverse set of therapeutic areas. Patrick has supported a variety of different organization types in the US, Europe and Asia to identify growth opportunities and increase shareholder value.
Prior to ClearView, Patrick held positions at A.T. Kearney, where he was part of the European Health & Lifesciences leadership team, built the European Center of Excellence for Biotechnology, and leveraged Data Science and Artificial Intelligence for faster and more robust decision making in R&D.
He holds an MBA of the University of St. Gallen, Switzerland and conducts research on strategic decision making at the IE University, Spain.
Debbi Amanti Belanger
Seth Berman
Klaus Bredl
Steven Chao
Rishi Dalsania
Kim Goh
Ketan Kapadia
Philip Kenner
David McClain
Richard Mynahan
Kevin Richard
Mike Rizzo
Ryan Tubman
Sam Ulin
Debbie Zhuang
Kristine Hyde
Sidnee Pinho
Jim Caruso
Steve Rubman
Lainey Miller
Brian Gibbs
Jonathan Betts
Dean Griffiths
Jonathan Hodgson
Slater Hurst
Dave Konciak
Charles Mathews
Rohit Kumar
Mike Roy
Beko Binder
Jessica Berard
Peter Goldman
Maneesh Gujrati
Austin Hubbert
Jonny Juliano
Owen Im
Andrew Kang
Patrick Kuettner
Joanna Lee
Alexander Lehrman
Alec Marchuk
Matthew Murphy
Mike Murray
Soyeon Park
Olivia Piccione
Matthew Pfister
Sarah Stapleton
Kai-Ming Pu
Kelsey Yardumian
Vini De Nadalal